EP 2042170 B1 20200115 - Creatine composition and use
Title (en)
Creatine composition and use
Title (de)
Kreatinzusammensetzung und Verwendung
Title (fr)
Composition de créatine et utilisation
Publication
Application
Priority
- EP 04256094 A 20041001
- GB 0323240 A 20031003
Abstract (en)
[origin: EP1520580A1] The invention relates to the preparation and use of compositions for increasing endurance in a mammal and the treatment prevention and delaying of endurance fatigue. The compositions contain creatine and an alkaline substance. The compositions also have use in the reduction of the perception of fatigue during or after endurance exercise.
IPC 8 full level
A61K 31/198 (2006.01); A61K 9/00 (2006.01); A61K 47/00 (2006.01); A61P 3/00 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A23L 33/10 (2016.07); A61K 31/198 (2013.01); A61P 3/00 (2017.12); A61P 43/00 (2017.12); A23L 2/52 (2013.01); A23V 2002/00 (2013.01)
C-Set (source: EP)
Citation (examination)
ANDREW R JAGIM ET AL: "A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate", JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, BIOMED CENTRAL LTD, LO, vol. 9, no. 1, 13 September 2012 (2012-09-13), pages 43, XP021107679, ISSN: 1550-2783, DOI: 10.1186/1550-2783-9-43
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
HR LT LV MK
DOCDB simple family (publication)
EP 1520580 A1 20050406; EP 2042170 A1 20090401; EP 2042170 B1 20200115; ES 2769577 T3 20200626; GB 0323240 D0 20031105
DOCDB simple family (application)
EP 04256094 A 20041001; EP 08019225 A 20041001; ES 08019225 T 20041001; GB 0323240 A 20031003